Arteriosclerosis and Thrombosis, Vol 13, 1-10, Copyright © 1993 by American Heart Association
ARTICLES |
M Mehrabian, JH Qiao, R Hyman, D Ruddle, C Laughton and AJ Lusis
Department of Medicine, University of California, Los Angeles 90024.
Previous studies have shown that distal mouse chromosome 1 contains the apolipoprotein AII (apoAII) gene, encoding the second most abundant apolipoprotein in high density lipoproteins (HDLs), as well as a gene termed Ath-1 that controls aortic fatty streak development and HDL cholesterol levels in response to a high-fat, high-cholesterol diet. We report genetic studies confirming that the genes are distinct. Using molecular markers for mouse chromosome 1, we have further mapped the two genes, and our results indicate that they are separated by a minimum of 2 cM. We also report evidence that in mice on a low-fat chow diet, the apoAII gene locus influences HDL cholesterol levels. Thus, statistical analysis of two sets of recombinant inbred strains revealed concordant segregation patterns of HDL cholesterol levels and the apoAII gene locus. The effect of apoAII expression on HDL cholesterol levels was further tested by using a congenic strain that exhibits increased apoAII synthesis in comparison to the background strain. The results support the concept that increased synthesis of apoAII results in increased HDL cholesterol levels. Unexpectedly, increased expression of apoAII appeared to promote rather than retard aortic fatty streak development.
This article has been cited by other articles:
![]() |
B. J. Bennett, S. S. Wang, X. Wang, X. Wu, and A. J. Lusis Genetic Regulation of Atherosclerotic Plaque Size and Morphology in the Innominate Artery of Hyperlipidemic Mice Arterioscler Thromb Vasc Biol, March 1, 2009; 29(3): 348 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Seidelmann, C. Kuo, N. Pleskac, J. Molina, S. Sayers, R. Li, J. Zhou, P. Johnson, K. Braun, C. Chan, et al. Athsq1 Is an Atherosclerosis Modifier Locus With Dramatic Effects on Lesion Area and Prominent Accumulation of Versican Arterioscler Thromb Vasc Biol, December 1, 2008; 28(12): 2180 - 2186. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sumiyoshi, H. Mokuno, T. Iesaki, K. Shimada, T. Miyazaki, A. Kume, T. Kiyanagi, K. Kuremoto, Y. Watanabe, N. Tada, et al. Deletion of the Fc receptors {gamma} chain preserves endothelial function affected by hypercholesterolaemia in mice fed on a high-fat diet Cardiovasc Res, December 1, 2008; 80(3): 463 - 470. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W. Castellani, C. N. Nguyen, S. Charugundla, M. M. Weinstein, C. X. Doan, W. S. Blaner, N. Wongsiriroj, and A. J. Lusis Apolipoprotein AII Is a Regulator of Very Low Density Lipoprotein Metabolism and Insulin Resistance J. Biol. Chem., April 25, 2008; 283(17): 11633 - 11644. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Wang, W. Shi, X. Wang, L. Velky, S. Greenlee, M. T. Wang, T. A. Drake, and A. J. Lusis Mapping, Genetic Isolation, and Characterization of Genetic Loci That Determine Resistance to Atherosclerosis in C3H Mice Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2671 - 2676. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Birjmohun, G. M. Dallinga-Thie, J. A. Kuivenhoven, E. S.G. Stroes, J. D. Otvos, N. J. Wareham, R. Luben, J. J.P. Kastelein, K.-T. Khaw, and S. M. Boekholdt Apolipoprotein A-II Is Inversely Associated With Risk of Future Coronary Artery Disease Circulation, October 30, 2007; 116(18): 2029 - 2035. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Wang, E. E. Schadt, H. Wang, X. Wang, L. Ingram-Drake, W. Shi, T. A. Drake, and A. J. Lusis Identification of Pathways for Atherosclerosis in Mice: Integration of Quantitative Trait Locus Analysis and Global Gene Expression Data Circ. Res., August 3, 2007; 101(3): e11 - e30. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. L. Cervino, A. Darvasi, M. Fallahi, C. C. Mader, and N. F. Tsinoremas An Integrated in Silico Gene Mapping Strategy in Inbred Mice Genetics, January 1, 2007; 175(1): 321 - 333. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Farber and J. F. Medrano Fine Mapping Reveals Sex Bias in Quantitative Trait Loci Affecting Growth, Skeletal Size and Obesity-Related Traits on Mouse Chromosomes 2 and 11 Genetics, January 1, 2007; 175(1): 349 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Estrada-Smith, A. R. Collins, X. Wang, C. Crockett, L. Castellani, A. J. Lusis, and R. C. Davis Impact of Chromosome 2 Obesity Loci on Cardiovascular Complications of Insulin Resistance in LDL Receptor-Deficient C57BL/6 Mice. Diabetes, August 1, 2006; 55(8): 2265 - 2271. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. de Beer, D. van der Westhuyzen, N. L. Whitaker, N. R. Webb, and F. C. de Beer SR-BI-mediated selective lipid uptake segregates apoA-I and apoA-II catabolism J. Lipid Res., October 1, 2005; 46(10): 2143 - 2150. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, P. Gargalovic, J. Wong, J. L. Gu, X. Wu, H. Qi, P. Wen, L. Xi, B. Tan, R. Gogliotti, et al. Hyplip2, a New Gene for Combined Hyperlipidemia and Increased Atherosclerosis Arterioscler Thromb Vasc Biol, October 1, 2004; 24(10): 1928 - 1934. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, R. Korstanje, D. Higgins, and B. Paigen Haplotype Analysis in Multiple Crosses to Identify a QTL Gene Genome Res., September 1, 2004; 14(9): 1767 - 1772. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Welch, S. Bretschger, P.-Z. Wen, M. Mehrabian, N. Latib, J. Fruchart-Najib, J. C. Fruchart, C. Myrick, and A. J. Lusis Novel QTLs for HDL levels identified in mice by controlling for Apoa2 allelic effects: confirmation of a chromosome 6 locus in a congenic strain Physiol Genomics, March 12, 2004; 17(1): 48 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Allayee, A. Ghazalpour, and A. J. Lusis Using Mice to Dissect Genetic Factors in Atherosclerosis Arterioscler Thromb Vasc Biol, September 1, 2003; 23(9): 1501 - 1509. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang and B. Paigen Quantitative Trait Loci and Candidate Genes Regulating HDL Cholesterol: A Murine Chromosome Map Arterioscler Thromb Vasc Biol, September 1, 2002; 22(9): 1390 - 1401. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W. Castellani and A. J. Lusis ApoA-II Versus ApoA-I: Two for One Is Not Always a Good Deal Arterioscler Thromb Vasc Biol, December 1, 2001; 21(12): 1870 - 1872. [Full Text] [PDF] |
||||
![]() |
F. Blanco-Vaca, J. C. Escola-Gil, J. M. Martin-Campos, and J. Julve Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein J. Lipid Res., November 1, 2001; 42(11): 1727 - 1739. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Schiller, N. Kubo, W. A. Boisvert, and L. K. Curtiss Effect of {gamma}-Irradiation and Bone Marrow Transplantation on Atherosclerosis in LDL Receptor-Deficient Mice Arterioscler Thromb Vasc Biol, October 1, 2001; 21(10): 1674 - 1680. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Welch, S. Bretschger, N. Latib, M. Bezouevski, Y. Guo, N. Pleskac, C.-P. Liang, C. Barlow, H. Dansky, J. L. Breslow, et al. Localization of atherosclerosis susceptibility loci to chromosomes 4 and 6 using the Ldlr knockout mouse model PNAS, July 3, 2001; 98(14): 7946 - 7951. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Hedrick, L. W. Castellani, H. Wong, and A. J. Lusis In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions J. Lipid Res., April 1, 2001; 42(4): 563 - 570. [Abstract] [Full Text] |
||||
![]() |
L. W. Castellani, A. M. Goto, and A. J. Lusis Studies With Apolipoprotein A-II Transgenic Mice Indicate a Role for HDLs in Adiposity and Insulin Resistance Diabetes, March 1, 2001; 50(3): 643 - 651. [Abstract] [Full Text] |
||||
![]() |
T. Claudel, M. D. Leibowitz, C. Fiévet, A. Tailleux, B. Wagner, J. J. Repa, G. Torpier, J.-M. Lobaccaro, J. R. Paterniti, D. J. Mangelsdorf, et al. Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor PNAS, February 15, 2001; (2001) 41609298. [Abstract] [Full Text] |
||||
![]() |
M. Mehrabian, L. W. Castellani, P.-Z. Wen, J. Wong, T. Rithaporn, S. Y. Hama, G. P. Hough, D. Johnson, J. J. Albers, G. A. Mottino, et al. Genetic control of HDL levels and composition in an interspecific mouse cross (CAST/Ei C57BL/6J) J. Lipid Res., December 1, 2000; 41(12): 1936 - 1946. [Abstract] [Full Text] |
||||
![]() |
J. C. Escolà-Gil, J. Julve, A. Marzal-Casacuberta, J. Ordóñez-Llanos, F. González-Sastre, and F. Blanco-Vaca Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia J. Lipid Res., August 1, 2000; 41(8): 1328 - 1338. [Abstract] [Full Text] |
||||
![]() |
A. Venkateswaran, J. J. Repa, J.-M. A. Lobaccaro, A. Bronson, D. J. Mangelsdorf, and P. A. Edwards Human White/Murine ABC8 mRNA Levels Are Highly Induced in Lipid-loaded Macrophages. A TRANSCRIPTIONAL ROLE FOR SPECIFIC OXYSTEROLS J. Biol. Chem., May 5, 2000; 275(19): 14700 - 14707. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Roest, Y. T. van der Schouw, J. D. Banga, M. J. Tempelman, P. G. de Groot, J. J. Sixma, and D. E. Grobbee Plasminogen Activator Inhibitor 4G Polymorphism Is Associated With Decreased Risk of Cerebrovascular Mortality in Older Women Circulation, January 4, 2000; 101(1): 67 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Subbanagounder, N. Leitinger, P. T. Shih, K. F. Faull, and J. A. Berliner Evidence That Phospholipid Oxidation Products and/or Platelet-Activating Factor Play an Important Role in Early Atherogenesis : In Vitro and In Vivo Inhibition by WEB 2086 Circ. Res., August 20, 1999; 85(4): 311 - 318. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Dansky, S. A. Charlton, J. L. Sikes, S. C. Heath, R. Simantov, L. F. Levin, P. Shu, K. J. Moore, J. L. Breslow, and J. D. Smith Genetic Background Determines the Extent of Atherosclerosis in ApoE-Deficient Mice Arterioscler Thromb Vasc Biol, August 1, 1999; 19(8): 1960 - 1968. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Braschi, T. A-M. Neville, M.-C. Vohl, and D. L. Sparks Apolipoprotein A-I charge and conformation regulate the clearance of reconstituted high density lipoprotein in vivo J. Lipid Res., March 1, 1999; 40(3): 522 - 532. [Abstract] [Full Text] |
||||
![]() |
D. L. Silver, X.-c. Jiang, and A. R. Tall Increased High Density Lipoprotein (HDL), Defective Hepatic Catabolism of ApoA-I and ApoA-II, and Decreased ApoA-I mRNA in ob/ob Mice. POSSIBLE ROLE OF LEPTIN IN STIMULATION OF HDL TURNOVER J. Biol. Chem., February 12, 1999; 274(7): 4140 - 4146. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gu, M. W. Johnson, and A. J. Lusis Quantitative Trait Locus Analysis of Plasma Lipoprotein Levels in an Autoimmune Mouse Model : Interactions Between Lipoprotein Metabolism, Autoimmune Disease, and Atherogenesis Arterioscler Thromb Vasc Biol, February 1, 1999; 19(2): 442 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tall, C. Welch, D. Applebaum-Bowden, and M. Wassef Interaction of Diet and Genes in Atherogenesis Report of an NHLBI Working Group Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 3326 - 3331. [Abstract] [Full Text] |
||||
![]() |
R. Katzman, M.-Y. Zhang, P. J. Chen, N. Gu, S. Jiang, T. Saitoh, X. Chen, M. Klauber, R. G. Thomas, W. T. Liu, et al. Effects of apolipoprotein E on dementia and aging in the Shanghai Survey of Dementia Neurology, September 1, 1997; 49(3): 779 - 785. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-O. Mowri, J. R. Patsch, A. M. Gotto Jr, and W. Patsch Apolipoprotein A-II Influences the Substrate Properties of Human HDL2 and HDL3 for Hepatic Lipase Arterioscler Thromb Vasc Biol, June 1, 1996; 16(6): 755 - 762. [Abstract] [Full Text] |
||||
![]() |
K. Ikewaki, L. A. Zech, M. Kindt, H. B. Brewer Jr, and D. J. Rader Apolipoprotein A-II Production Rate Is a Major Factor Regulating the Distribution of Apolipoprotein A-I Among HDL Subclasses LpA-I and LpA-I:A-II in Normolipidemic Humans Arterioscler Thromb Vasc Biol, March 1, 1995; 15(3): 306 - 312. [Abstract] [Full Text] |
||||
![]() |
C. Warden, C. Hedrick, J. Qiao, L. Castellani, and A. Lusis Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II Science, July 23, 1993; 261(5120): 469 - 472. [Abstract] [PDF] |
||||
![]() |
M. C. de Beer, D. M. Durbin, L. Cai, N. Mirocha, A. Jonas, N. R. Webb, F. C. de Beer, and D. R. van der Westhuyzen Apolipoprotein A-II Modulates the Binding and Selective Lipid Uptake of Reconstituted High Density Lipoprotein by Scavenger Receptor BI J. Biol. Chem., May 4, 2001; 276(19): 15832 - 15839. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Shih, Y.-R. Xia, X.-P. Wang, E. Miller, L. W. Castellani, G. Subbanagounder, H. Cheroutre, K. F. Faull, J. A. Berliner, J. L. Witztum, et al. Combined Serum Paraoxonase Knockout/Apolipoprotein E Knockout Mice Exhibit Increased Lipoprotein Oxidation and Atherosclerosis J. Biol. Chem., June 2, 2000; 275(23): 17527 - 17535. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Claudel, M. D. Leibowitz, C. Fievet, A. Tailleux, B. Wagner, J. J. Repa, G. Torpier, J.-M. Lobaccaro, J. R. Paterniti, D. J. Mangelsdorf, et al. Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor PNAS, February 27, 2001; 98(5): 2610 - 2615. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |